It's adaptable for both low and high data line speed from 1Mbps to 32Gbps to meet different test condition. Besides, it achieves 16-bit voltage resolution with high output swing. A self calibration ...

A smartphone-based app shows potential for measuring presbyopic addition, with strong correlation to clinical measurements.

Patients with glaucoma using fixed combination therapy may experience faster presbyopia progression than those using monotherapy.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Double data rate (DDR) memory interface is used in an increasing number of electronic products to increase the efficiency of memory access. Factors such as signal propagation delay, reflection, and ...

LENZ Therapeutics' aceclidine outshines Vuity for presbyopia with better safety and duration. Click for LENZ's market potential and revenue growth forecast.

A second phase 3 pivotal clinical trial investigating phentolamine ophthalmic solution 0.75% for the treatment of presbyopia met its primary and key secondary endpoints, according to a press ...

Opus Genetics' eye drop shows promise for age-related vision loss in Phase 3 trial. Company plans FDA filing to expand medication's approved uses.

(RTTNews) - Viatris Inc. (VTRS), Thursday announced positive top-line results from VEGA-3, evaluating MR-141 in patients with presbyopia, the progressive loss of the ability to focus on close objects.

--Viatris Inc., a global healthcare company, today announced positive top-line results from VEGA-3, the second pivotal Phase 3 trial evaluating MR-141 in treating presbyopia. Presbyopia is the ...

Topline data were announced from a phase 3 trial evaluating MR-141 (phentolamine ophthalmic solution 0.75%) for the treatment of presbyopia.

Presbyopia is the progressive loss of ability to focus on near objects that typically becomes noticeable in the early to mid-40s. As the eye ages, the ability to focus for reading and other tasks that ...